Abstract
Background: The most important investigations since the first publication on opiorphin, in 2006, are summarized in this review. Opiorphin is a human endogenous pentapeptide (Gln-Arg-Phe-Ser-Arg) which inhibits both the Neutral EndoPeptidase (NEP) and aminopeptidase N (AP-N), protecting enkephalins from degradation by these ectopeptidases, thus activating endogenous enkephalin-related opioid pathways.
Objective: In this review we highlight the in vitro and in vivo effects of opiorphin.
Results: We examine in detail the structure-activity relationship studies addressed in order to identify the amino acids of opiorphin sequence required to functional interactions with its targets and to design its metabolically stable analogs. The modulation of emotionalrelated behaviors and effects on smooth muscle motility including their resulting therapeutic implication are also analysed. In addition, the in vitro potency of opiorphin and its metabolically stable analogs on opioid receptor binding by enkephalin-related peptides are also summarized. Finally, quantitative or semiquantitative analytical methods of opiorphin on various biological samples are cited.
Conclusion: The advantages and difficulties of therapeutic applications of opiorphin peptide and its synthetic derivatives are discussed.
Keywords: Opiorphin, AP-N and NEP enkephalinases, enkephalins, analgesia, opioid receptors, emotional behaviors, smooth muscle motility, analytical methods.
Graphical Abstract
Current Bioactive Compounds
Title:Human Opiorphin an Endogenous Inhibitor of Enkephalin-Inactivating Ectopeptidases that Displays Antinociception: A Review
Volume: 12 Issue: 4
Author(s): Maria Wollemann and Catherine Rougeot
Affiliation:
Keywords: Opiorphin, AP-N and NEP enkephalinases, enkephalins, analgesia, opioid receptors, emotional behaviors, smooth muscle motility, analytical methods.
Abstract: Background: The most important investigations since the first publication on opiorphin, in 2006, are summarized in this review. Opiorphin is a human endogenous pentapeptide (Gln-Arg-Phe-Ser-Arg) which inhibits both the Neutral EndoPeptidase (NEP) and aminopeptidase N (AP-N), protecting enkephalins from degradation by these ectopeptidases, thus activating endogenous enkephalin-related opioid pathways.
Objective: In this review we highlight the in vitro and in vivo effects of opiorphin.
Results: We examine in detail the structure-activity relationship studies addressed in order to identify the amino acids of opiorphin sequence required to functional interactions with its targets and to design its metabolically stable analogs. The modulation of emotionalrelated behaviors and effects on smooth muscle motility including their resulting therapeutic implication are also analysed. In addition, the in vitro potency of opiorphin and its metabolically stable analogs on opioid receptor binding by enkephalin-related peptides are also summarized. Finally, quantitative or semiquantitative analytical methods of opiorphin on various biological samples are cited.
Conclusion: The advantages and difficulties of therapeutic applications of opiorphin peptide and its synthetic derivatives are discussed.
Export Options
About this article
Cite this article as:
Wollemann Maria and Rougeot Catherine, Human Opiorphin an Endogenous Inhibitor of Enkephalin-Inactivating Ectopeptidases that Displays Antinociception: A Review, Current Bioactive Compounds 2016; 12 (4) . https://dx.doi.org/10.2174/1573407212666160425171005
DOI https://dx.doi.org/10.2174/1573407212666160425171005 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pregnancy in Type 2 Diabetes Mellitus - Problems & Promises
Current Diabetes Reviews Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
Current Vascular Pharmacology Current Research on Opioid Receptor Function
Current Drug Targets The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews Effects of Salinomycin on Cancer Stem Cell in Human Lung Adenocarcinoma A549 Cells
Medicinal Chemistry Perspective of Molecular Hydrogen in the Treatment of Sepsis
Current Pharmaceutical Design Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists
Current Medicinal Chemistry A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Mast Cell – Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications
CNS & Neurological Disorders - Drug Targets Antagonists of the Vasopressin V1 Receptor and of the β<sub>1</sub>-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes-but the Mechanisms Differ
Current Neuropharmacology Nonviral Approach for Targeted Nucleic Acid Delivery
Current Medicinal Chemistry Retinoid-Induced Limb Malformations
Current Pharmaceutical Design Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Current Neuropharmacology The Inflammatory Milieu of the Degenerate Disc: Is Mesenchymal Stem Cell-based Therapy for Intervertebral Disc Repair a Feasible Approach?
Current Stem Cell Research & Therapy The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets Altered Calcium Handling in Reperfusion Injury
Medicinal Chemistry Oxygen Sensing in Health and Disease
Current Respiratory Medicine Reviews Newer Insights in Personalized and Evidence Based Medicine- the Role of MicroRNAs
Current Pharmacogenomics and Personalized Medicine Islet Inflammation in Type 2 Diabetes (T2D): From Endothelial to β-Cell Dysfunction
Current Immunology Reviews (Discontinued)